regeneron

Me and a couple people throughout Regeneron have expressed our support for Palestine ever since Len and George sent a company wide email that was pretty much one sided in showing support for Israel while at the same time condemning Palestinians and equating them to Hamas. Also many of us were...

Regeneron Pharmaceuticals, Inc. (REGN) reported a 36% jump in earnings for the first quarter of 2020 helped by higher revenue. The results exceeded analysts’ expectations. The company is advancing REGN-COV2, a novel investigational antibody “cocktail” treatment designed to prevent and treat the...

Regeneron Pharmaceuticals reported a 371% jump in earnings for the fourth quarter helped by higher product sales and an income tax benefit as well as management of costs and expenses. Net product sales grew to $1.1 billion from $979 million last year, helped by higher sales from Eylea injection...

I am wondering how large the Lucentis sales force is currently? I have found this tool that estimates sales force sizes for various products, but wanted to get a second opinion. https://mddetails.com/insights/u-s-sales-force-estimator/ Also, how large is the US sales force for Eylea? Thanks!

Hi All, I was wondering how big the Eylea and Lucentis US-only sales forces are? I found this tool, but wasn't sure how accurate the information was. https://mddetails.com/insights/u-s-sales-force-estimator/ Thanks!

What the scene looks like at IOPS in Rensselaer..... Just GOOGLE IT.

Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will be a real threat to Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...

Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will end the monopoly of Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis...

Does Regeneron drug test interns not on the clinical side?

Does anyone know how Regeneron's sales team compares to Sanofi's and about how many people they have in the field? Seems like a pretty equal split?

From leaders like Len/George to the lowest admin scum... https://www.streetinsider.com/Corporate+News/Merus+N.V.+%28MRUS%29+Says+U.S.+Court+of+Appeals+Denies+Regenerons+%28REGN%29+Petition+to+Rehear+the+Panels+Decision+on+018+Patent/13632058.html This article says it all. Do some more research...